During the past decade, Elblandklinikum Riesa conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Elblandklinikum Riesa" #1 sponsor was "Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest" with 2 trials, followed by "AIO-Studien-gGmbH" with 1 trials sponsored, "Ipsen" with 1 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored and "Leipzig Heart Institute GmbH" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Elblandklinikum Riesa" #1 collaborator was "Celgene" with 1 trials as a collaborator, "Crolll Gmbh" with 1 trials as a collaborator, "Heart Center Leipzig - University Hospital" with 1 trials as a collaborator and "Servier Deutschland GmbH" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Elblandklinikum Riesa" are "Advanced or Metastatic Renal Cell Carcinoma" (1 trials), "Chronic Heart Failure" (1 trials), "Locally Advanced Pancreatic Cancer" (1 trials), "Metastatic Colorectal Cancer" (1 trials) and "Metastatic Pancreatic Cancer" (1 trials). Many other conditions were trialed in "Elblandklinikum Riesa" in a lesser frequency.

Most popular intervention types in "Elblandklinikum Riesa" are "Drug" (2 trials), "Other" (2 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Archival Tumor Tissue Sample" (1 trials), "Atherectomy/Thrombectomy" (1 trials), "CRT-D implantation" (1 trials), "CRT-P implantation" (1 trials) and "FerInject" (1 trials). Other intervention names were less common.

The vast majority of trials in "Elblandklinikum Riesa" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Elblandklinikum Riesa". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Elblandklinikum Riesa, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Elblandklinikum Riesa, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".